Published in Aliment Pharmacol Ther on July 01, 2006
Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer (2006) 0.94
Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer? Fam Cancer (2013) 0.77
Analysis of candidate genes in occurrence and growth of colorectal adenomas. J Oncol (2009) 0.75
Quality indicators to assess a colorectal cancer prevention program. Int J Technol Assess Health Care (2013) 0.75
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (1998) 10.35
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Alleles of the APC gene: an attenuated form of familial polyposis. Cell (1993) 3.84
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol (1997) 3.08
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91
Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature (1991) 2.87
Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat (1996) 2.80
Automatic record hash coding and linkage for epidemiological follow-up data confidentiality. Methods Inf Med (1998) 2.80
Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.74
Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology (1991) 2.43
Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet (1988) 2.42
Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy (2011) 2.32
Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique (2003) 2.25
Association of p53 mutations with short survival in colorectal cancer. Gastroenterology (1994) 2.19
Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet (1995) 2.13
Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Fédération Francophone de Cancérologie Digestive. Gastroenterol Clin Biol (2008) 2.06
Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res (2000) 2.06
Survival and acquired genetic alterations in colorectal cancer. Gastroenterology (1992) 2.02
Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol (1995) 1.97
Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer (1998) 1.96
Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique (2008) 1.88
Multiple genetic alterations in distal and proximal colorectal cancer. Lancet (1989) 1.87
Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum (2001) 1.87
Concerted nonsyntenic allelic loss in human colorectal carcinoma. Science (1988) 1.81
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev (1991) 1.70
Tobacco, alcohol, and colorectal tumors: a multistep process. Am J Epidemiol (1995) 1.65
Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. The Association Nationale des Gastroentérologues des Hôpitaux and Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505) Gastroenterology (1998) 1.62
Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg (2006) 1.59
Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol (2000) 1.59
How to ensure data security of an epidemiological follow-up: quality assessment of an anonymous record linkage procedure. Int J Med Inform (1998) 1.58
Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther (2005) 1.58
Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol (2000) 1.57
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. Am J Hum Genet (1997) 1.54
Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg (2002) 1.48
Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. Int J Epidemiol (1991) 1.46
PTEN germ-line mutations in juvenile polyposis coli. Nat Genet (1998) 1.45
Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias. Leukemia (2009) 1.45
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: a prospective study. Int J Gynecol Cancer (2008) 1.43
Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet (2008) 1.41
[Appendectomy, cholecystectomy, cholelithiasis and colorectal cancer. A retrospective case control study at the Côte-d'Or]. Gastroenterol Clin Biol (1991) 1.40
Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab (2000) 1.39
[How to choose in practice a model to describe the geographic variation of cancer incidence? Example of gastrointestinal cancers from Côte-d'Or]. Rev Epidemiol Sante Publique (2002) 1.39
Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut (2004) 1.39
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol (2005) 1.39
Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum (2004) 1.38
RFLP identified by the anonymous DNA segment OL VII E10 at 18q21.3 (HGM no. D18S8). Nucleic Acids Res (1987) 1.38
Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer (2001) 1.38
[A diagnostic strategy for isolated pulmonary nodules less than 2 cm in diameter]. Rev Mal Respir (2002) 1.37
[Disposable versus reusable biopsy forceps. A prospective cost analysis in the gastrointestinal endoscopy unit of the Dijon University Hospital]. Gastroenterol Clin Biol (2001) 1.37
Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg (1995) 1.34
Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol (1999) 1.34
Colon cancer in France: evidence for improvement in management and survival. Gut (2002) 1.34
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer (2006) 1.33
A national survey of acute hepatitis E in France. Aliment Pharmacol Ther (2008) 1.32
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int J Cancer (1998) 1.29
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database. Diabetologia (2012) 1.28
Adenoma--carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer (1992) 1.28
European health systems and cancer care. Ann Oncol (2003) 1.27
Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev (2004) 1.25
Risk tables for genetic counselling in some common congenital malformations. J Med Genet (1974) 1.23
Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer (2000) 1.22
Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg (2008) 1.17
Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy. Ann Surg (2001) 1.17
Epidemiological evidence for distinguishing subsites of colorectal cancer. J Epidemiol Community Health (1989) 1.15
Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study. Aliment Pharmacol Ther (2009) 1.15
Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds. The EVA Study Group. Stroke (1996) 1.15
Influence of socioeconomic status on prognosis of colorectal cancer. A population-based study in Côte D'Or, France. Cancer (1993) 1.14
Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke (1999) 1.14
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer (1997) 1.12
Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening. Br J Cancer (2001) 1.12
[Factors of early prognosis in medically treated haemorrhages of upper gastrointestinal tract in cirrhotic patients. Statistical study (author's transl)]. Pathol Biol (Paris) (1981) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Improvement of operative mortality after curative resection for gastric cancer: population-based study. World J Surg (2000) 1.11
Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol (1993) 1.11
Comparability of colorectal cancer survival data in three European population-based registries. Eur J Cancer Prev (1998) 1.11
Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol (2005) 1.11
Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Gut (2002) 1.10
Cancer incidence and mortality in France in 1975-95. Eur J Cancer Prev (1997) 1.10
Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials. Clin Pharmacol Ther (2011) 1.10
What is the best way to assess microsatellite instability status in colorectal cancer? Study on a population base of 462 colorectal cancers. Am J Surg Pathol (2004) 1.10
Modelling time-dependent hazard ratios in relative survival: application to colon cancer. J Clin Epidemiol (2001) 1.08
Letter: Peptic ulcer bleeding and liver cirrhosis--different diseases and different prognosis, too? Aliment Pharmacol Ther (2013) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet (2003) 1.07